2[2]Odom RB, James WD, Berger TG, et al. Andrews' Diseases of the Skin[M]. 9th ed, Philadelphia: WB Saunders, 2000. 189-190.
3[3]Ueda M, Makinodan R, Matsumura M, et al. Successful treatment of amyopathic dermatomyositis with topical tacrolimus[J]. Br J Dermatol, 2003, 148(3): 595-596.
4[4]Sugisaki K, Takeda I, Iwadate H, et al. Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine/cyclophosphamide in two patients with amyopathic dermatomyositis[J]. Fukushima J Med Sci, 2002,48(2): 103-110.
4[2]El-Azhary RA,Pakzad SY.Amyopathic dermatomyositis:retrospective review of 37cases[J].J Am Acad Dermatol,2002,46(4):560-565.
5[3]Morihara K,Katoh N,Hirano S,et al.Amyopathic dermatomyositis presenting during pregnancy[J].J Am Acad Dermatol,2004,51(5):838-840.
6[4]Arita N,Ito MR,Nakatani K,et al.Analysis of human cytomegalovirus infection of an autopsy case of dermatomyositis with rapidly progressive interstitial pneumonia:the possible correlation between the viral genome and its related protein on the pathogenesis[J].Ryumachi,2002,42(3):597-604.
7[6]Callen JP.When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer[J].Arch Dermatol,2002,38:969-971.
8[7]Sontheimer RD.The management of dermatomyositis:current treatment options[J].Expert Opinion on Pharmacotherapy,2004,5(5):1083-1099
9[8]Sontheimer RD,Miyagawa S.Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis[J].Journal of the American Academy of Dermatology,2003,48(5):797-798.
10[9]High WA,Cohen JB,Murphy BA,et al.Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis[J].Journal of the American Academy of Dermatology,2003,49(2):295-298.
